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The onset of the novel Coronavirus Disease 2019 (COVID-19) out-
break in Wuhan, China, suggests animal-to-person spread and later
person-to-person spread. The complete clinical picture following
COVID-19 infection is not yet fully understood. A recent report on over
72,000 COVID-19 cases by the Chinese Center for Disease Control and
Prevention showed the case fatality rate was overall 2.3%. The mor-
tality rises to 8% in patients between 70 and 79-years-old, and spikes to
14.8% in those aged 80 and above [1]. Sorhabi et al. give an in-
formative and comprehensive account of the timeline, etiology, symp-
toms, supportive treatment, and transmission prevention of COVID-19
[2].
The WHO's declaration of COVID-19 to be a Public Health
Emergency of International Concern is attributable to the high case
fatality rates in China and the global economic effect of COVID-19,
which may compound the current ongoing influenza epidemic [3].
Furthermore, there is the potential for higher death rates in countries
with vulnerable health systems in resource-limited regions. The ability
to control local transmission depends on the application of the princi-
ples of rapid identification, prevention, and control, followed by patient
isolation, rapid diagnosis, and contact tracing. Some countries remain
ill-equipped with limited diagnostic capacity, resulting in delays from
suspected case identification to vector confirmation and patient isola-
tion, which increases the risk of disease transmission. [4] Though, 74%
of countries in Africa have an influenza pandemic preparedness plan;
however, most are outdated and inadequate to deal with a global
pandemic such as COVID-19 [5].
Recent epidemics and pandemics (e.g., severe acute respiratory
syndrome (SARS), H1N1 pandemic, Middle East respiratory syndrome
(MERS), and Ebola) have highlighted the need to reinforce national
public health capabilities, including disease-surveillance systems and
health care workforce. Pandemic preparedness requires specific
training in surveillance, epidemic response, and diagnostic testing.
Strengthening health care systems worldwide, particularly in resource-
poor settings, is imperative. Recurrent novel pandemics is our new
global reality.
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